Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Danone, Reckitt race to ramp up US baby formula supply amid shortage

Stock Markets May 25, 2022 05:25AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: French food group Danone logo is seen at the company headquarters in Rueil-Malmaison near Paris, France, February 18, 2021. REUTERS/Gonzalo Fuentes/File Photo

By Richa Naidu

LONDON (Reuters) -Danone SA has been doubling shipments to the United States of Neocate formula for infants allergic to cow's milk while Enfamil maker Reckitt is also working to boost supplies amid a nationwide shortage, company executives said on Wednesday.

Top manufacturer Abbott Laboratories (NYSE:ABT) in February recalled dozens of types of its Similac, Alimentum and EleCare formulas, creating one of the most urgent food shortages in recent history for U.S. families.

Reckitt said it is working "extremely closely" with the U.S. Food & Drug Administration (FDA) on ways to increase supply, including expediting the approval of some products made at a facility in Mexico.

"Accelerating this process, while still ensuring high safety and quality standards, would allow us to significantly increase supply to U.S. consumers," Robert Cleveland, Reckitt's Senior Vice President of North America and Europe Nutrition, said in prepared remarks that he may read later on Wednesday at a hearing with U.S. lawmakers on the shortages.

The British company, which supplies roughly half the U.S. baby formula market, said it is also working with the U.S. Department of Agriculture (USDA) to expand the availability of formula under a programme that helps low-income families.

Danone - the world's second-biggest baby formula maker after Nestle but a relatively small player in the United States with less than 5% of market share - is stepping up supply of Neocate more broadly.

“The Abbott recall affected 38 markets – it’s not only the U.S.," said Magdalena Broseta, Danone's Vice President General Counsel of Specialized Nutrition.

"Our factory in Europe is serving multiple markets...of course, the numbers and the volumes and the U.S. are bigger just because of the size of the market.”

The French company declined to say how many cans or tonnes of product it is exporting.

When asked if Danone would bring its flagship Aptamil formula into the United States, Broseta said the company had been discussing a number of options with authorities, adding that it was easier to increase imports of products that were already available in the country than introduce new ones.

"Their focus is to try to unblock any logistical situations that other players could be facing," she added. "It's a bit early to say what exactly would that entail."

Broseta said Danone is producing more formula at its plant in Liverpool, Britain and not rerouting product from elsewhere.

“We will keep on serving our existing geographies at the level of their respective demand," she said.

U.S. states, manufacturers to decide if gov't benefits apply to imported baby formula

Danone, Reckitt race to ramp up US baby formula supply amid shortage
 

Related Articles

Dow Futures Trade Lower After Positive Week
Dow Futures Trade Lower After Positive Week By Investing.com - Jun 26, 2022 2

By Oliver Gray  Investing.com - U.S. stock futures were trading lower during Sunday's evening deals, easing from a major rebound last week as investors monitored growing recession...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email